|
Market Data
Labcorp Holdings Inc.
Labcorp Holdings Inc. is a leading provider of comprehensive laboratory services, operating through two primary segments: Diagnostics Laboratories and Biopharma Laboratory Services. The company's core business involves a wide array of diagnostic testing, ranging from routine blood and urine analyses to specialized tests for complex conditions like cancer, infectious diseases, and genetic disorders. Labcorp also offers essential services to the biopharmaceutical industry, supporting drug development and medical device testing. Serving a diverse clientele that includes healthcare providers, pharmaceutical companies, and managed care organizations, Labcorp facilitates critical healthcare decisions and advances scientific research through its extensive testing capabilities. Its online and mobile platforms provide convenient access to services and results for both patients and healthcare professionals.
LH is currently trading at $270.89, giving Labcorp Holdings Inc. a market cap of 22.30B and a P/E ratio of 25.4. Today's range spans $266.68–$273.63, with shares opening at $266.68 and moving up $0.22 (0.1%) from the prior close. DailyIQ's technical score sits at 64/100 (HOLD) with a news sentiment reading of 72/100.
Over the past year LH has traded between $209.38 and $293.72 - the current price is +29.4% off the 52-week low and -7.8% from the high. 31 analysts cover the stock with a Buy consensus and a mean 12-month target of $310.06 (range $270.00–$347.00), implying upside of +14.5%.
LH is in a holding pattern - 64/100 technical score, HOLD signal, price at $270.89 (in the upper portion of its 52-week range), sentiment bullish at 72/100. (P/E: 25.4) At 22.30B in Healthcare market cap, HOLD phases like this are where the thesis is re-evaluated and position sizing decisions get made by both longs and shorts. Annual range: $209.38–$293.72. The next catalyst, not the current setup, determines the exit from this range.
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $4.12 | - | - |
| Q4'25 | $3.94 | $4.07 | +3.2% |
| Q3'25 | $4.14 | $4.18 | +1.0% |
| Q2'25 | $4.18 | $4.35 | +4.1% |
| Q1'25 | $3.73 | $3.84 | +2.8% |
| Q4'24 | $3.39 | $3.45 | +1.7% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $3.5B | - | - |
| Q4'25 | $3.6B | $3.5B | -1.2% |
| Q3'25 | - | $3.6B | - |
| Q2'25 | - | $3.5B | - |
| Q1'25 | - | $3.3B | - |
| Q4'24 | - | $3.3B | - |
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).